On Holding and LOEWE Unveil LightSpray Cloudmonster A Fusion of Performance and Luxury
Monthly Retail Trade Sales Report from Census Bureau Highlights Consumer Spending Trends
UK Spy Chief Warns of Moment of Consequence as West Faces Mounting Threats from Russia and China
Fed Holds Rates Steady Amid Divided Decision
Nvidias 5 Trillion Market Cap Surpasses Six of Worlds Top 10 Stock Markets Amid AI Rally
Analysts Identify Adani Power Netweb Technologies and Others for Potential NearTerm Gains Amid Market Weakness
Shoulder Innovations Inc SI Q1 2026 Earnings NarrowerthanExpected Loss Despite No Reported Revenue
Vivani Medical VANI Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction
NewtekOne Inc 850 Fixed Rate Senior Notes due 2029 NEWTG Q1 2026 Earnings EPS Slightly Misses Estimates Revenue Not Disclosed
Serve Robotics Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Phase Stock Declines
SCCF Q4 2025 Earnings Massive EPS Surprise of 782 Driven by Strong Operational Performance
Gilat Satellite Networks GILT Q1 2026 Earnings Massive EPS Beat Surprises Market Stock Gains
American Tower AMT Holds Near Resistance as REIT Sector Seeks Direction
Starry Sea Acquisition Corp Rights SSEAR Holds Steady at 017 Amid Thin Trading
BRC Inc BRCC Dips Past Key Levels as Volume Increases
Pelican Acquisition PELI Shares Tumble 1179 Support Levels in Focus
Insulet PODD Holds Steady Near Support as Trading Volume Remains Subdued
VTGN Q1 2026 Earnings NarrowerthanExpected Loss Amid Clinical Progress
Rocket Pharmaceuticals Inc RCKT Q1 2026 Earnings Clinical Progress Overshadowed by Slight EPS Miss and Capital Concerns
HMY Q2 2016 Earnings EPS Miss by 5475 Yet Stock Rallies 716
TriSalus Life Sciences TLSI Q1 2026 Earnings EPS Surges Past Expectations Yet Stock Slips
CHCT Q1 2026 Earnings EPS Surges Past Estimates with 449 Beat
YJ Q3 2024 Earnings Significant EPS Miss Triggers Stock Decline
Understanding Bad Credit Personal Loans Key Information for Borrowers
SOFI Q1 2026 Earnings EPS Slightly Below Estimates Stock Dips Marginally
Inhibrx Biosciences INBX Surges Over 5 as Biotech Momentum Builds